A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

NCT04222790 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

OTHER_GOV

Sponsor class

Conditions

Early Breast Cancer

Interventions

DRUG: monosialic gangliosides
OTHER: Placebo

Sponsor

Henan Cancer Hospital